GenIP taps parent group for £200,000 convertible loan to fund software rollout
What's the deal? GenIPDealroom has a profile for this one. Try Dealroom →, an AIM-listed provider of AI-driven services that help organisations commercialise their innovations, has raised £200,000 through a convertible loan note from Tekcapital Europe. The note runs for four years, carries 10% annual interest that accrues and compounds, and is unsecured. GenIP can redeem it early without penalty.
Who's backing it? The sole funder is Tekcapital Europe, a wholly owned subsidiary of Tekcapital plcDealroom has a profile for this one. Try Dealroom → and already a substantial shareholder. That makes the deal a related-party transaction under AIM Rule 13.
What's the money for? Proceeds will fund the commercial rollout of GenIP's subscription-based software platform for technology-transfer decisions, and broader growth plans. The sum equals roughly 23% of GenIP's current market capitalisation.
How does conversion work? Both principal and accrued interest can convert into new ordinary shares at the closing mid-market price on the day before conversion. But the Tekcapital concert party already holds about 48.95% of voting rights, so conversion is capped under Rule 9 of the City Code to avoid triggering a mandatory takeover offer.
Why now? The loan follows a £350,000 share placing in May. First-half 2026 revenue fell to about $54,000, while the pretax loss widened to roughly $800,000 — leaving the small, cash-consuming business in need of near-term support.
What could go wrong? The compounding 10% interest adds a growing financing burden over the four-year term. Because conversion happens at the prevailing market price, the eventual share count cannot be set now, raising the prospect of dilution for other holders.
The signal: At £200,000, this sits toward the lower end of funding rounds, and its related-party source makes it more a financing bridge than evidence of fresh outside validation. The deal shows a parent group backstopping a loss-making subsidiary rather than independent investors validating its model.
Read more: ae.marketscreener.com
Image credit: Generated with Gemini
